No abstract available.
Injections, Intralesional ; Isotretinoin ; Triamcinolone ; Triamcinolone Acetonide

In this paper, the legend in Figure 3 (B) was given incorrectly.

BACKGROUND: Skin lesions and pain are the most distinctive features of herpes zoster. Light-emitting diode (LED) therapy is an effective treatment known for its wound-healing effects. OBJECTIVE: To determine whether the LED treatment affects wound healing and acute pain in acute herpes zoster ophthalmicus. METHODS: We recruited 28 consecutive Korean patients with acute herpes zoster ophthalmicus for the study. In the control group (group A), 14 subjects received oral famcyclovir. In the experimental group (group B), 14 subjects received oral famcyclovir and 830 nm LED phototherapy on days 0, 4, 7, and 10. In order to estimate the time for wound healing, we measured the duration from the vesicle formation to when the lesion crust fell off. The visual analogue scale (VAS) was used for the estimation of pain on days 4, 7, 10, and 14. RESULTS: The mean time required for wound healing was 13.14+/-2.34 days in group B and 15.92+/-2.55 days in group A (p=0.006). From day 4, the mean VAS score showed a greater improvement in group B, compared with group A. A marginal but not statistically significant difference in the VAS scores was observed between the two groups (p=0.095). CONCLUSION: LED treatment for acute herpes zoster ophthalmicus leads to faster wound healing and a lower pain score.
Acute Pain ; Herpes Zoster ; Herpes Zoster Ophthalmicus ; Humans ; Phototherapy ; Pilot Projects ; Skin ; Wound Healing

No abstract available.
Fingers ; Mucins

Herpes simplex virus (Herpesvirus hominis), a member of the herpeptoviridae family, is among the most common infectious viral pathogens in humans. Types of HSV can be subdivided into HSV-1 and HSV-2 on the basis of physiological, serologic and epidemiologic differences, although both are closely related immunologically and DNA sequence homology. HSV-1 is frequently associated with oropharyngeal, eye and skin infections, while HSV-2 is most commonly associated with genital tract infections. Characteristically after the primary infection, HSV can be linked to latency in neural tissue. Reactivation of HSV can be triggered by sunburn, fever, stress, menstruation and local trauma. Here we report a case of reactivation of herpes simplex virus type 2 in foot dorsum followed by repetitive friction due to Sandals' trap.
Base Sequence ; Female ; Fever ; Foot* ; Friction* ; Herpes Simplex* ; Herpesvirus 1, Human ; Herpesvirus 2, Human ; Humans ; Menstruation ; Reproductive Tract Infections ; Simplexvirus* ; Skin ; Sunburn

No abstract available.
Lichen Planus ; Lichens

No abstract available.
Drug Eruptions*

No abstract available.
Steatocystoma Multiplex

BACKGROUND: Treatments including intralesional corticosteroid injection, pressure therapy, cryotherapy, and various laser therapies have had limited success for keloids and hypertrophic scars. OBJECTIVE: This trial evaluated the efficacy of a combination of 578 nm copper bromide laser and the more traditional intralesional corticosteroid injection for the treatment of keloids and hypertrophic scars with respect to scar color. METHODS: Keloids or hypertrophic scars of 12 Korean patients were treated five times by the combined treatment at 4-week intervals. Clinical improvement was assessed by the physicians' global assessment (PGA) comparing pre- and post-treatment photographs, as well as 4 weeks after the last treatment. Erythema intensity was quantified using a mexameter. RESULTS: Most scars showed significant clinical improvement in PGA and decreased erythema intensity after 5 treatments. All patients showed improvements in symptoms like pruritus. CONCLUSION: The combined treatment is effective for keloids and hypertrophic scars, especially when the telangiectatic portion of the scars is prominent. The adjunctive use of 578 nm copper bromide laser decreased the telangiectatic side effects of an intralesional corticosteroid injection by reducing the vascular components of scars.
Cicatrix ; Cicatrix, Hypertrophic* ; Copper* ; Cryotherapy ; Erythema ; Humans ; Keloid* ; Laser Therapy ; Pilot Projects* ; Pruritus

No abstract available.